3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
42
Colonic Neoplasms
14
Rectal Neoplasms
13
Neoplasms
12
Neoplasm Metastasis
12
Head and Neck Neoplasms
6
Esophageal Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
4
Pancreatic Neoplasms
4
Carcinoma, Squamous Cell
4
Breast Neoplasms
4
Recurrence
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Adenocarcinoma Of Esophagus
3
Triple Negative Breast Neoplasms
2
Gastrointestinal Neoplasms
2
Cholangiocarcinoma
2
Carcinoma
2
Biliary Tract Neoplasms
2
Urinary Bladder Neoplasms
1
Solid Tumors
1
Ovarian Neoplasms
1
Inflammatory Breast Neoplasms
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
Gallbladder Neoplasms
1
Fallopian Tube Neoplasms
1
Exanthema
1
Interventions
Octreotide
5
Everolimus
4
pasireotide
3
lanreotide
3
ganitumab
2
gallium Ga 68 dotatate
2
cabozantinib
2
Nivolumab
2
Erlotinib Hydrochloride
2
surufatinib
1
pertuzumab
1
nintedanib
1
ibrutinib
1
fosbretabulin
1
conatumumab
1
cixutumumab
1
carfilzomib
1
arginyllysine
1
aflibercept
1
Temozolomide
1
Sunitinib
1
Somatostatin
1
Random Allocation
1
Ramucirumab
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Capecitabine
1
Bevacizumab
1
Axitinib
1
(18F)GTP1
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoid Tumor
×
Panitumumab
×
Clear all
No trials found.